The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
Amphetamine use disorder
Collaborative care
Emergency medicine
Implementation science
Opioid use disorder
Pragmatic clinical trials
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
30
04
2021
revised:
09
09
2021
accepted:
15
11
2021
pubmed:
26
12
2021
medline:
19
4
2022
entrez:
25
12
2021
Statut:
ppublish
Résumé
Opioid use disorder (OUD) and related comorbid conditions are highly prevalent among patients presenting to emergency department (ED) settings. Research has developed few comprehensive disease management strategies for at-risk patients presenting to the ED that both decrease illicit opioid use and improve initiation and retention in medication treatment for OUD (MOUD). The research team conducted a pilot pragmatic clinical trial that randomized 40 patients presenting to a single ED to a collaborative care intervention (n = 20) versus usual care control (n = 20) conditions. Interviewers blinded to patient intervention and control group status followed-up with participants at 1, 3, and 6 months after presentation to the ED. The 3-month Emergency Department Longitudinal Integrated Care (ED-LINC) collaborative care intervention for patients at risk for OUD included: 1) a Brief Negotiated Interview at bedside, 2) overdose education and facilitation of MOUD, 3) longitudinal proactive care management, 4) utilization of the statewide health information exchange platform for 24/7 tracking of recurrent ED utilization, and 5) weekly caseload supervision that incorporated measurement-based care treatment assessment with stepped-up care for patients with recalcitrant symptoms. Overall, the ED-LINC intervention was feasibly delivered and acceptable to patients. The pilot study achieved >80% follow-up rates at 1, 3, and 6 months. In adjusted longitudinal mixed model regression analyses, no statistically significant differences existed in days of opioid use over the past 30 days for ED-LINC intervention patients when compared to patients receiving usual care (incidence-rate ratio (IRR) 1.50, 95% CI 0.54-4.16). The unadjusted mean number of days of illicit opioid use decreased at the 1-month and 3-month follow-up time points for both groups. ED-LINC intervention patients had increased rates of MOUD initiation compared to control patients (50% versus 30%); intervention versus control comparisons did not achieve statistical significance, although power to detect significant differences in the pilot was limited. The ED-LINC intervention for patients with OUD can be feasibly implemented and warrants testing in larger scale, adequately powered randomized pragmatic clinical trial investigations. gov NCT03699085.
Identifiants
pubmed: 34952745
pii: S0740-5472(21)00392-5
doi: 10.1016/j.jsat.2021.108666
pmc: PMC9056018
mid: NIHMS1766457
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Banques de données
ClinicalTrials.gov
['NCT03699085']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108666Subventions
Organisme : NIDA NIH HHS
ID : K23 DA039974
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002317
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Med Care. 2005 May;43(5):436-44
pubmed: 15838407
Addiction. 2002 Sep;97(9):1183-94
pubmed: 12199834
Addict Behav. 2006 Sep;31(9):1661-9
pubmed: 16446045
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Behav Health Serv Res. 2019 Jan;46(1):151-163
pubmed: 30069622
Ann Emerg Med. 2019 May;73(5):481-487
pubmed: 30616926
J Subst Abuse Treat. 2021 Jul;126:108318
pubmed: 34116817
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
Am J Addict. 2021 Mar;30(2):183-191
pubmed: 33301230
Am J Emerg Med. 2019 Sep;37(9):1787-1790
pubmed: 30803850
Addiction. 2016 May;111(5):892-902
pubmed: 26662858
J Gen Intern Med. 2017 Jun;32(6):660-666
pubmed: 28194688
Ann Emerg Med. 2021 Dec;78(6):759-772
pubmed: 34353655
Ann Surg. 2013 Mar;257(3):390-9
pubmed: 23222034
MMWR Morb Mortal Wkly Rep. 2015 Jul 10;64(26):719-25
pubmed: 26158353
Drug Alcohol Depend. 2017 Dec 1;181:58-62
pubmed: 29035705
Am J Prev Med. 2019 Jun;56(6):875-881
pubmed: 31003811
Implement Sci. 2017 Aug 29;12(1):108
pubmed: 28851459
J Emerg Med. 2016 Nov;51(5):498-507
pubmed: 27624507
JAMA Surg. 2021 May 1;156(5):430-474
pubmed: 33688908
Am J Addict. 2019 Sep;28(5):409-412
pubmed: 31251426
Health Aff (Millwood). 2017 Oct 1;36(10):1748-1753
pubmed: 28971919
Adm Policy Ment Health. 2009 Jan;36(1):24-34
pubmed: 19104929
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1189-1197
pubmed: 32881854
J Subst Abuse Treat. 2016 Jan;60:101-9
pubmed: 26256769
Drug Alcohol Depend. 2016 Jun 01;163:40-7
pubmed: 27062245
Inj Prev. 2019 Jun;25(3):191-198
pubmed: 29436397
Trauma Surg Acute Care Open. 2021 Jan 28;6(1):e000550
pubmed: 33553651
Addiction. 2017 Aug;112(8):1395-1405
pubmed: 28127808
N Engl J Med. 2019 Jan 3;380(1):71-79
pubmed: 30601750
JAMA Netw Open. 2018 Sep 7;1(5):e182908
pubmed: 30646184
Addiction. 2014 May;109(5):754-65
pubmed: 24450612
N Engl J Med. 2018 Dec 27;379(26):2487-2490
pubmed: 30586522
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):279-285
pubmed: 29518069
JAMA. 2010 May 19;303(19):1921-8
pubmed: 20483968
Psychiatr Serv. 2016 Dec 1;67(12):1348-1354
pubmed: 27417898
Ann Intern Med. 2021 Jul;174(7):899-909
pubmed: 33819055
JAMA Netw Open. 2020 May 1;3(5):e204561
pubmed: 32391893
Ann Emerg Med. 2018 Oct;72(4):420-431
pubmed: 29880438
Drug Alcohol Depend. 2021 Oct 1;227:109003
pubmed: 34482046
Drug Alcohol Depend. 2020 Jul 1;212:108041
pubmed: 32470753
J Trauma Stress. 2015 Oct;28(5):391-400
pubmed: 26467327
J Psychiatr Res. 2011 May;45(5):626-9
pubmed: 21035130
Acad Emerg Med. 2016 Apr;23(4):424-32
pubmed: 26910248
JAMA. 2015 Apr 28;313(16):1636-44
pubmed: 25919527
J Subst Abuse Treat. 2017 Nov;82:12-21
pubmed: 29021110
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
J Subst Abuse Treat. 2021 Aug;127:108342
pubmed: 34134882
Ann Intern Med. 2018 Aug 7;169(3):137-145
pubmed: 29913516
N Engl J Med. 2019 Jun 6;380(23):2246-2255
pubmed: 31167053
J Addict Med. 2020 Mar/Apr;14(2):99-112
pubmed: 32209915
N Engl J Med. 2010 Dec 30;363(27):2611-20
pubmed: 21190455
J Addict Med. 2015 Sep-Oct;9(5):358-67
pubmed: 26406300
J Subst Abuse Treat. 2018 Nov;94:29-34
pubmed: 30243414
Arch Intern Med. 2003 Apr 14;163(7):821-9
pubmed: 12695273
J Community Health. 2018 Jun;43(3):598-603
pubmed: 29305727
J Am Coll Emerg Physicians Open. 2021 Mar 23;2(2):e12408
pubmed: 33778807
Drug Alcohol Depend. 2019 Jul 1;200:34-39
pubmed: 31082666
Pain. 2008 Sep 30;139(1):127-135
pubmed: 18455314
Arch Gen Psychiatry. 2004 May;61(5):498-506
pubmed: 15123495
J Subst Abuse Treat. 2020 Jan;108:88-94
pubmed: 31200985
AIDS. 1991 Feb;5(2):181-5
pubmed: 2031690
Arch Gen Psychiatry. 1993 Sep;50(9):739-50
pubmed: 8357299
Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207
pubmed: 24500948
JAMA Intern Med. 2017 Oct 1;177(10):1480-1488
pubmed: 28846769
Epidemiol Infect. 2017 Mar;145(4):746-754
pubmed: 27917738
Addict Behav. 2013 Mar;38(3):1776-81
pubmed: 23254228
Subst Abus. 2016;37(1):70-5
pubmed: 26566712
JAMA. 2002 Dec 11;288(22):2836-45
pubmed: 12472325
Drug Alcohol Depend. 2018 Dec 1;193:14-20
pubmed: 30326396
J Addict Med. 2015 Sep-Oct;9(5):417-26
pubmed: 26428361
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174
Arch Intern Med. 2011 Mar 14;171(5):425-31
pubmed: 21403039
JAMA. 2010 Aug 4;304(5):527-35
pubmed: 20682932
J Subst Abuse Treat. 2020 Feb;109:80-85
pubmed: 31810594
J Subst Abuse Treat. 2012 Jan;42(1):87-94
pubmed: 21831562
Psychiatry. 2018 Summer;81(2):141-157
pubmed: 29533154
Ann Emerg Med. 2005 Feb;45(2):118-27
pubmed: 15671966
JAMA. 2020 Dec 22;324(24):2550-2551
pubmed: 33351045